Literature DB >> 17619178

Effects of pregnancy on nicotine self-administration and nicotine pharmacokinetics in rats.

Mark G Lesage1, Daniel E Keyler, Danielle Burroughs, Paul R Pentel.   

Abstract

RATIONALE: Because of the adverse effects of smoking during pregnancy, understanding the factors that influence maternal smoking may help in developing better treatments to help women quit smoking during pregnancy. Animal models could be useful for this purpose.
OBJECTIVE: The purpose of the present study was to begin the development of an animal model of smoking during pregnancy by initially characterizing nicotine self-administration (NSA) in pregnant rats. Another purpose was to begin to explore the effects of pregnancy on nicotine pharmacokinetics in rats.
MATERIALS AND METHODS: In experiment 1, female rats self-administering nicotine during 23-h sessions were examined throughout gestation and lactation. In experiment 2, locomotor activity was measured during pregnancy to assess further potential motor effects of pregnancy. Experiments 3 and 4 compared the single-dose pharmacokinetics of nicotine in male, nonpregnant female, and pregnant females in the first and third trimester of pregnancy and the first week of lactation.
RESULTS: NSA decreased over the course of pregnancy with NSA significantly lower in the third trimester compared to nonpregnant controls. NSA remained suppressed for up to 10 days into lactation. Locomotor behavior was also significantly suppressed during the second and third trimesters and throughout lactation. Nicotine elimination was slower in pregnant females compared to nonpregnant females only in the third trimester.
CONCLUSIONS: NSA, locomotor behavior, and nicotine elimination in rats are decreased during late pregnancy. The present study is the first to characterize NSA during pregnancy in animals, providing a potential model of maternal smoking in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619178     DOI: 10.1007/s00213-007-0830-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Changes in progressive ratio responding for intravenous cocaine throughout the reproductive process in female rats.

Authors:  G S Hecht; N E Spear; L P Spear
Journal:  Dev Psychobiol       Date:  1999-09       Impact factor: 3.038

2.  Fluctuations of maternal smoking during pregnancy.

Authors:  Kate E Pickett; Lauren S Wakschlag; Lanting Dai; Bennett L Leventhal
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

3.  Hepatic microsomal metabolism of drugs during pregnancy in the rat.

Authors:  M E Dean; B H Stock
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

4.  Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine.

Authors:  Mark G LeSage; Dan E Keyler; Don Shoeman; Donna Raphael; Gregory Collins; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2002-05       Impact factor: 3.533

5.  Changes in ethanol consumption by pregnant pigtailed macaques.

Authors:  R H Elton; M E Wilson
Journal:  J Stud Alcohol       Date:  1977-11

6.  Comparing the prevalence of smoking in pregnant and nonpregnant women, 1985 to 1986.

Authors:  D F Williamson; M K Serdula; J S Kendrick; N J Binkin
Journal:  JAMA       Date:  1989-01-06       Impact factor: 56.272

7.  Heavily smoking women who cannot quit in pregnancy: evidence of pharmacokinetic predisposition.

Authors:  P Selby; R Hackman; B Kapur; J Klein; G Koren
Journal:  Ther Drug Monit       Date:  2001-06       Impact factor: 3.681

8.  Accelerated metabolism of nicotine and cotinine in pregnant smokers.

Authors:  Delia Dempsey; Peyton Jacob; Neal L Benowitz
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

9.  Do pregnant women who report a reduction in cigarette consumption consume less tobacco?

Authors:  K Haug; O P Foss; J M Kvamme
Journal:  Scand J Prim Health Care       Date:  1994-12       Impact factor: 2.581

Review 10.  The effects of tobacco use during and after pregnancy on exposed children.

Authors:  M D Cornelius; N L Day
Journal:  Alcohol Res Health       Date:  2000
View more
  8 in total

Review 1.  Role of progesterone in nicotine addiction: evidence from initiation to relapse.

Authors:  Wendy J Lynch; Mehmet Sofuoglu
Journal:  Exp Clin Psychopharmacol       Date:  2010-12       Impact factor: 3.157

2.  Sex differences in nicotine self-administration in rats during progressive unit dose reduction: implications for nicotine regulation policy.

Authors:  Patricia Grebenstein; Danielle Burroughs; Yan Zhang; Mark G LeSage
Journal:  Pharmacol Biochem Behav       Date:  2013-11-04       Impact factor: 3.533

3.  A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers.

Authors:  Xuesi M Shao; Briana Lopez; David Nathan; Julian Wilson; Emmanuel Bankole; Hayk Tumoyan; Alexandra Munoz; Jorge Espinoza-Derout; Kamrul M Hasan; Scarlett Chang; Christina Du; Amiya P Sinha-Hikim; Kabirullah Lutfy; Theodore C Friedman
Journal:  J Neurosci Methods       Date:  2019-07-27       Impact factor: 2.390

4.  Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy.

Authors:  Patricia E Grebenstein; Danielle Burroughs; Samuel A Roiko; Paul R Pentel; Mark G LeSage
Journal:  Drug Alcohol Depend       Date:  2015-04-07       Impact factor: 4.492

5.  Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.

Authors:  Michael E Saladin; Erin A McClure; Nathaniel L Baker; Matthew J Carpenter; Viswanathan Ramakrishnan; Karen J Hartwell; Kevin M Gray
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

Review 6.  Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Authors:  Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

7.  Sex differences in attenuation of nicotine reinstatement after individual and combined treatments of progesterone and varenicline.

Authors:  Natashia Swalve; John R Smethells; Marilyn E Carroll
Journal:  Behav Brain Res       Date:  2016-04-21       Impact factor: 3.332

8.  Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study.

Authors:  Nathaniel L Baker; Kevin M Gray; Viswanathan Ramakrishnan; Rachel L Tomko; Erin A McClure; Matthew J Carpenter; Michael E Saladin
Journal:  Addict Biol       Date:  2020-05-31       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.